These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationships of opacification in the nasal sinuses, rhinosinusitis, and antiresorptive agent-related osteonecrosis of the jaw. Matsumoto Y, Yokoi H, Ikeda T, Kawada M, Saito K. Auris Nasus Larynx; 2020 Dec; 47(6):996-1002. PubMed ID: 32591168 [Abstract] [Full Text] [Related]
8. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H, Kobashi Y, Yamazoe S, Munetomo Y, Mogami T, Nomura T. Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278 [Abstract] [Full Text] [Related]
15. A Case of Osteomyelitis of the Mandibular Condyle Secondary to Bisphosphonate-related Osteonecrosis of the Jaw. Kato H, Uchibori M, Nakanishi Y, Kaneko A. Tokai J Exp Clin Med; 2020 Sep 20; 45(3):126-130. PubMed ID: 32901900 [Abstract] [Full Text] [Related]
16. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones. Li YF, Hu J. Int J Oral Maxillofac Surg; 2013 Jan 20; 42(1):149-50. PubMed ID: 22763138 [No Abstract] [Full Text] [Related]
19. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis? Ristow O, Gerngroß C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, Hahnefeld L, Otto S, Pautke C. J Oral Maxillofac Surg; 2014 May 20; 72(5):903-10. PubMed ID: 24485975 [Abstract] [Full Text] [Related]